Evidence map›Paper›PMID 36134084›Full record

ArticleCureus2022

Dexmethylphenidate-Induced Rhabdomyolysis by Interaction With Aromatase Inhibitor.

Derrick Huang, Shane Dluzneski, Michael Hughes, Samyr Elbadri, Latha Ganti

Abstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Derrick HuangEmergency Medicine, University of Central Florida College of Medicine, Ocala, USA.
Shane DluzneskiEmergency Medicine, University of Central Florida College of Medicine, Ocala, USA.
Michael HughesEmergency Medicine, University of Central Florida College of Medicine, Ocala, USA.
Samyr ElbadriEmergency Medicine, University of Central Florida College of Medicine, Ocala, USA.
Latha GantiEmergency Medicine, HCA Florida Ocala Hospital, Ocala, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhabdomyolysis secondary to prescription drug-drug interactions can be an overlooked life-threatening emergency. Amphetamines and similar substances have been associated with muscle lysis secondary to increased sympathetic activity that can cause myotoxicity, hyperthermia, and increased muscular activity. Anabolic steroids may also be a predisposing factor in developing rhabdomyolysis. A high index of suspicion for drug-induced rhabdomyolysis in a patient presenting with atraumatic extremity pain can facilitate rapid diagnosis and treatment. We present a case of drug-induced rhabdomyolysis likely secondary to a previously unreported medication interaction.

Indexed as

amphetamine-dextroamphetaminearomatase inhibitorattention deficit hyperactivity disorder (adhd)dexmethylphenidategrowth hormone replacement therapyletrozolenon-traumatic rhabdomyolysispituitary hormone replacement

Identifiers

PMID36134084
PMCPMC9470210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.